Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-05-19

Clinical Trial Update: A Study to Evaluate Topical Phenylephrine Gel in the Management of Faecal Incontinence [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating topical phenylephrine gel for fecal incontinence has been withdrawn from the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topical Phenylephrine Gel (phenylephrine)

Snippet

Sponsor: S.L.A. Pharma AG | Conditions: Faecal Incontinence | Phase 3 | Status: WITHDRAWN